Welcome to Thursday’s Overnight Health Care.
Regeneron filed for emergency authorization of its antibody COVID-19 treatment drug, just hours after President Trump claimed it basically cured him. Mitch McConnell hasn’t been to the White House in months, and a new analysis shows Americans’ job-based health care is continually getting more expensive.
We’ll start with Regeneron:
Regeneron asks for emergency authorization of coronavirus treatment Trump received
Biotech company Regeneron late Wednesday applied for emergency authorization for an experimental antibody treatment praised by President Trump.
“Subsequent to our discussions with regulatory authorities, we have submitted a request to the U.S. Food and Drug Administration for an Emergency Use Authorization (EUA) for our REGN-COV2 investigational antibody combination for COVID-19,” the company said in a news release.
The move came just hours after the president praised the efficacy of the treatment in a short video message posted on Twitter.
“They gave me Regeneron, it’s called Regeneron,” Trump said in the five-minute video Wednesday afternoon. “It was unbelievable. I felt good immediately. I felt as good three days ago as I do now.”
Why it matters: Trump was taking several drugs for his illness, so it’s not clear which helped him feel better. He claimed he has the “emergency use authorization all set,” but the FDA is supposed to make decisions based on science and not demands from the president. Regeneron’s drug is still undergoing clinical trials, and while early results seem promising, the company has not released data to back up its claims.
Read more here.
McConnell says he hasn’t visited White